| ALP | alkaline phosphatase |
| BIC | bone–implant contact |
| BMI | body mass index |
| BOP | bleeding on probing |
| BV/TV | bone volume fraction |
| CAL | clinical attachment level |
| CD26 | cluster of differentiation 26 |
| cAMP | cyclic adenosine monophosphate |
| CRP | C-reactive protein |
| DPP-4 | dipeptidyl peptidase-4 |
| EMA | European Medicines Agency |
| EX-4 | exendin-4 |
| FAERS | FDA Adverse Event Reporting System |
| FDA | Food and Drug Administration |
| GIP | glucose-dependent insulinotropic polypeptide |
| GLP-1 | glucagon-like peptide-1 |
| GLP-1R | glucagon-like peptide-1 receptor |
| GLP-1RA | glucagon-like peptide-1 receptor agonist |
| HbA1c | hemoglobin A1c |
| HG | high glucose |
| HO-1 | heme oxygenase-1 |
| ICMJE | International Committee of Medical Journal Editors |
| IL-1β | interleukin-1 beta |
| IL-6 | interleukin-6 |
| IL-10 | interleukin-10 |
| LPS | lipopolysaccharide |
| M1 | classically activated macrophage phenotype |
| M2 | alternatively activated macrophage phenotype |
| MAPK | mitogen-activated protein kinase |
| MBL | marginal bone loss |
| MEDLINE | Medical Literature Analysis and Retrieval System Online |
| micro-CT | micro-computed tomography |
| NF-kappaB | nuclear factor kappa B |
| NR | not reported |
| Nrf2 | nuclear factor erythroid 2-related factor 2 |
| OPG | osteoprotegerin |
| Osx | Osterix |
| PD | probing depth |
| PDLSC | periodontal ligament stem cell |
| PI | plaque index |
| PLGA | poly(lactic-co-glycolic acid) |
| RANKL | receptor activator of nuclear factor kappa B ligand |
| RCT | randomized controlled trial |
| Runx2 | runt-related transcription factor 2 |
| SANRA | Scale for the Assessment of Narrative Review Articles |
| SDF-1 | stromal-cell-derived factor-1 |
| SGLT2 | sodium–glucose cotransporter 2 |
| T2D | type 2 diabetes |
| TNF-α | tumor necrosis factor-alpha |
| TRAP | tartrate-resistant acid phosphatase |
| WHO | World Health Organization |
| Wnt | Wingless/Integrated signaling pathway |